2-Methyl-1,2,3,4-tetrahydroisoquinoline hydrochloride, 95.0%, 250mg

3-Methylpyrrolidin-3-amine dihydrochloride, 98%, 100mg

DL-alpha-Lipoic Acid>99.0%(T)5g

1-(tert-Butyl) 5-methyl (tert-butoxycarbonyl)-L-glutamate, 98%, 10g

3-Chloro-2-iodo-thiophene, 98%, 250mg

3-(3-aminophenyl)-1,3-oxazolidin-2-one, 95.0%, 1g

n-Decyltriethoxysilane, 98%, 5g

2-(1-Pyrazolyl)benzyl Alcohol, 95.0%, 5g

tert-Butyl (2-hydroxycyclopentyl)carbamate, 97%, 100mg

(R)-(((((1-(6-Amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphoryl)bis(oxy))bis(methylene) diisopropyl dicarbonate, 95.0%, 25g

3-Cyano-2-fluoropyridine, 98.0%, 25g

5-Amino-1-benzylpiperidin-2-one, 95+%, 500mg

GC capillary column ROTI®Cap-1701, 10 m, 0.53 mm, 1.00 µm, 1 Piece(s)